From: The association between ADAM12 gene polymorphisms and osteoarthritis: an updated meta-analysis
Study author | Sex | Patient group | Control group | P-HWE | MAF | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GG | GC | CC | G | C | GG | GC | CC | G | C | ||||
Rs3740199 | |||||||||||||
Kerna [37]a | Male | 2 | 7 | 6 | 11 | 19 | 4 | 15 | 16 | 23 | 47 | 0.87 | 0.67 |
Female | 4 | 25 | 22 | 33 | 69 | 8 | 31 | 49 | 47 | 129 | 0.35 | 0.73 | |
Kerna [37]b | Male | 1 | 8 | 16 | 10 | 40 | 5 | 13 | 7 | 23 | 27 | 0.82 | 0.54 |
Female | 9 | 26 | 37 | 34 | 100 | 3 | 30 | 34 | 36 | 98 | 0.25 | 0.73 | |
Shin [38] | Male | 45 | 94 | 32 | 184 | 158 | 281 | 423 | 178 | 985 | 779 | 0.41 | 0.44 |
Female | 169 | 270 | 115 | 608 | 500 | 243 | 440 | 172 | 926 | 784 | 0.29 | 0.46 | |
Poonpet [41] | Male/Female | 42 | 102 | 56 | 186 | 214 | 54 | 100 | 46 | 208 | 192 | 0.98 | 0.48 |
Wang [25] | Male/Female | 44 | 84 | 36 | 172 | 156 | 51 | 102 | 47 | 204 | 196 | 0.77 | 0.50 |
Lou [39] | Male/Female | 42 | 78 | 32 | 162 | 142 | 44 | 93 | 42 | 181 | 177 | 0.60 | 0.50 |
Haberal [5] | Male/Female | 51 | 76 | 23 | 178 | 122 | 38 | 78 | 34 | 154 | 146 | 0.62 | 0.49 |
Aguilar [42] | Male/Female | 58 | 45 | 29 | 161 | 103 | 67 | 76 | 21 | 210 | 118 | 0.94 | 0.36 |
Rodriguez-Lopez [40]* | Male/Female | NA | NA | NA | 234 | 290 | NA | NA | NA | 261 | 327 | NA | 0.44 |
Rodriguez-Lopez [40]* | Male/Female | NA | NA | NA | 350 | 370 | NA | NA | NA | 652 | 744 | NA | 0.47 |
Rodriguez-Lopez [40]* | Male/Female | NA | NA | NA | 138 | 180 | NA | NA | NA | 147 | 239 | NA | 0.38 |
Study author | Sex | Patient group | Control group | P-HWE | MAF | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TT | TC | CC | T | C | TT | TC | CC | T | C | ||||
Rs1871054 | |||||||||||||
Lou [39] | Male/Female | 26 | 57 | 69 | 109 | 195 | 47 | 88 | 44 | 182 | 176 | 0.83 | 0.50 |
Wang [25] | Male/Female | 29 | 59 | 76 | 117 | 211 | 52 | 99 | 49 | 203 | 197 | 0.89 | 0.49 |
Haberal [5] | Male/Female | 43 | 67 | 40 | 153 | 147 | 41 | 70 | 39 | 152 | 148 | 0.41 | 0.49 |
Aguilar [42] | Male/Female | 24 | 76 | 32 | 124 | 140 | 21 | 90 | 53 | 132 | 196 | 0.07 | 0.60 |
Kerna [37]a | Male | 4 | 8 | 3 | 16 | 14 | 10 | 17 | 8 | 37 | 33 | 0.88 | 0.47 |
Female | 14 | 25 | 12 | 53 | 49 | 20 | 45 | 23 | 85 | 91 | 0.82 | 0.52 | |
Kerna [37]b | Male | 7 | 11 | 7 | 25 | 25 | 7 | 14 | 4 | 28 | 22 | 0.50 | 0.44 |
Female | 17 | 35 | 20 | 69 | 75 | 17 | 35 | 15 | 69 | 65 | 0.71 | 0.49 | |
Kerna [26] | Male | 3 | 7 | 10 | 13 | 27 | 14 | 29 | 8 | 57 | 45 | 0.27 | 0.45 |
Kerna [26]a | Male | 2 | 3 | 8 | 7 | 19 | 19 | 35 | 12 | 73 | 59 | 0.55 | 0.55 |
Fatima [24] | Male | 35 | 37 | 26 | 107 | 89 | 35 | 41 | 24 | 447 | 353 | 0.09 | 0.45 |
Female | 71 | 153 | 88 | 295 | 329 | 97 | 142 | 61 | 336 | 264 | 0.49 | 0.44 |
Study author | Sex | Patient group | Control group | P-HWE | MAF | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TT | TC | CC | T | C | TT | TC | CC | T | C | ||||
Rs1044122 | |||||||||||||
Wang [25] | Male/Female | 51 | 88 | 25 | 190 | 138 | 62 | 101 | 37 | 225 | 175 | 0.71 | 0.44 |
Lou [39] | Male/Female | 47 | 81 | 24 | 129 | 175 | 56 | 92 | 31 | 204 | 154 | 0.52 | 0.43 |
Kerna [26] | Male | 21 | 27 | 6 | 69 | 39 | 29 | 27 | 10 | 85 | 47 | 0.38 | 0.37 |
Female | 58 | 65 | 8 | 181 | 81 | 53 | 66 | 24 | 172 | 114 | 0.66 | 0.40 | |
Fatima [24] | Male | 40 | 39 | 9 | 119 | 57 | 53 | 39 | 8 | 145 | 55 | 0.83 | 0.28 |
Female | 125 | 144 | 46 | 394 | 236 | 172 | 102 | 26 | 446 | 154 | 0.06 | 0.27 |